Minor
Intravitreal THN391 in Diabetic Macular Oedema Secondary to Non-Proliferative Diabetic Retinopathy
Trial sites expanded: 7 → 10 locations
Therini Bio Pty LtdPhase 1 NCT06701721 Registry history of NCT06701721 on ClinicalTrials.gov (opens the registry)